Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

Magali Michaut, Suet‐Feung Chin, Ian J. Majewski, +43

Scientific Reports

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

Bo Li, Tríona Ní Chonghaile, Yue Fan, +20

Cancer Research

Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model

Frida Danielsson, Marie Skogs, Mikael Huss, +7

Proceedings of the National Academy of Sciences

Ensemble based system for whole-slide prostate cancer probability mapping using color texture features

Matthew D. DiFranco, Gillian O’Hurley, Elaine W. Kay, +2

Computerized Medical Imaging and Graphics

Image AnalysisMachine VisionMedical ImagingEngineeringPattern Recognition +11

Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer

Antoinette S. Perry, Gillian O’Hurley, Omer Raheem, +14

International Journal of Cancer

Epigenetic ChangeGeneticsMolecular BiologyCancer BiologyEpigenetics +19

Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer

Gillian O’Hurley, Christer Busch, Linn Fagerberg, +10

PLoS ONE

EngineeringPathologyTissue BiomarkersDiagnostic MarkersGene Expression Profiling +15

The role of secreted frizzled-related protein 2 expression in prostate cancer

Gillian O’Hurley, Antoinette S. Perry, Anthony O’Grady, +8

Histopathology

Carbonic anhydrase IX expression in prostate cancer

Liam Smyth, Gillian O’Hurley, A O’Grady, +3

Prostate Cancer and Prostatic Diseases

UrologyBiochemistryProstatic DiseaseMedicineTumor Biology +1

Investigation of molecular alterations of <i><scp>AKT</scp>‐3</i> in triple‐negative breast cancer

Gillian O’Hurley, Etáin Daly, Anthony O’Grady, +13

Histopathology

Identification of transcription factors associated with castration‐resistance: Is the serum responsive factor a potential therapeutic target?

Maria Prencipe, Stephen F. Madden, Amanda O’Neill, +7

The Prostate